1,2-dichloroethane increases expression ISO RGD:1320444 6480464 ethylene dichloride results in increased expression of LHFPL2 mRNA CTD PMID:28960355 1,2-dimethylhydrazine decreases expression ISO RGD:1320444 6480464 1, 2-Dimethylhydrazine results in decreased expression of LHFPL2 mRNA CTD PMID:22206623 17alpha-ethynylestradiol increases expression ISO RGD:1320444 6480464 Ethinyl Estradiol results in increased expression of LHFPL2 mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO RGD:1320444 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LHFPL2 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:1320443 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of LHFPL2 mRNA CTD PMID:30165855 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:27291303 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1320444 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LHFPL2 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1320444 6480464 Tetrachlorodibenzodioxin affects the expression of LHFPL2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1320444 6480464 Tetrachlorodibenzodioxin results in decreased expression of LHFPL2 mRNA CTD PMID:19465110 , PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1320444 6480464 Tetrachlorodibenzodioxin results in increased expression of LHFPL2 mRNA CTD PMID:17942748 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1320443 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of LHFPL2 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of LHFPL2 mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane increases expression ISO RGD:1320444 6480464 4, 4'-diaminodiphenylmethane results in increased expression of LHFPL2 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1320443 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of LHFPL2 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1320444 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of LHFPL2 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol increases expression ISO RGD:1320444 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of LHFPL2 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide decreases expression ISO RGD:1320444 6480464 Fenretinide results in decreased expression of LHFPL2 mRNA CTD PMID:28973697 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of LHFPL2 mRNA CTD PMID:22504374 aflatoxin B1 decreases expression ISO RGD:1320444 6480464 Aflatoxin B1 results in decreased expression of LHFPL2 mRNA CTD PMID:19770486 aflatoxin B1 increases methylation ISO RGD:1320443 6480464 Aflatoxin B1 results in increased methylation of LHFPL2 intron CTD PMID:30157460 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of LHFPL2 mRNA CTD PMID:20488242 all-trans-retinoic acid multiple interactions ISO RGD:1320444 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of LHFPL2 mRNA CTD PMID:30951980 all-trans-retinoic acid increases expression ISO RGD:1320443 6480464 Tretinoin results in increased expression of LHFPL2 mRNA CTD PMID:23724009 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of LHFPL2 mRNA CTD PMID:30779732 aristolochic acid A decreases expression ISO RGD:1320443 6480464 aristolochic acid I results in decreased expression of LHFPL2 mRNA CTD PMID:33212167 atrazine decreases expression ISO RGD:1320443 6480464 Atrazine results in decreased expression of LHFPL2 mRNA CTD PMID:22378314 benzene increases expression ISO RGD:1320443 6480464 Benzene results in increased expression of LHFPL2 mRNA CTD PMID:19162166 benzo[a]pyrene decreases expression ISO RGD:1320443 6480464 Benzo(a)pyrene results in decreased expression of LHFPL2 mRNA CTD PMID:20064835 benzo[a]pyrene affects methylation ISO RGD:1320443 6480464 Benzo(a)pyrene affects the methylation of LHFPL2 5' UTR more ... CTD PMID:27901495 , PMID:30157460 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of LHFPL2 mRNA CTD PMID:21839799 benzo[a]pyrene decreases expression ISO RGD:1320444 6480464 Benzo(a)pyrene results in decreased expression of LHFPL2 mRNA CTD PMID:19770486 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of LHFPL2 mRNA CTD PMID:25181051 bisphenol A increases methylation ISO RGD:1320443 6480464 bisphenol A results in increased methylation of LHFPL2 gene CTD PMID:31601247 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of LHFPL2 mRNA CTD PMID:33296240 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of LHFPL2 mRNA CTD PMID:30816183 more ... bisphenol A multiple interactions ISO RGD:1320443 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of LHFPL2 gene, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of LHFPL2 mRNA CTD PMID:28628672 , PMID:31601247 bisphenol A increases expression ISO RGD:1320443 6480464 bisphenol A results in increased expression of LHFPL2 mRNA CTD PMID:25047013 more ... calcitriol increases expression ISO RGD:1320443 6480464 Calcitriol results in increased expression of LHFPL2 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:1320443 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of LHFPL2 mRNA CTD PMID:21592394 carbon nanotube increases expression ISO RGD:1320444 6480464 Nanotubes more ... CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:1320443 6480464 CGP 52608 promotes the reaction [RORA protein binds to LHFPL2 gene] CTD PMID:28238834 copper atom increases expression EXP 6480464 Copper deficiency results in increased expression of LHFPL2 mRNA CTD PMID:26033743 copper(0) increases expression EXP 6480464 Copper deficiency results in increased expression of LHFPL2 mRNA CTD PMID:26033743 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of LHFPL2 mRNA CTD PMID:27523638 cyclosporin A increases expression ISO RGD:1320444 6480464 Cyclosporine results in increased expression of LHFPL2 mRNA CTD PMID:19770486 cyclosporin A increases expression ISO RGD:1320443 6480464 Cyclosporine results in increased expression of LHFPL2 mRNA CTD PMID:20106945 , PMID:25562108 dexamethasone decreases expression ISO RGD:1320444 6480464 Dexamethasone results in decreased expression of LHFPL2 mRNA CTD PMID:22733784 dexamethasone multiple interactions ISO RGD:1320443 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of LHFPL2 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of LHFPL2 mRNA CTD PMID:28628672 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of LHFPL2 mRNA CTD PMID:21266533 dimethylarsinic acid multiple interactions ISO RGD:1320444 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of LHFPL2 mRNA CTD PMID:34876320 ethanol multiple interactions ISO RGD:1320443 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of LHFPL2 mRNA CTD PMID:29432896 ethanol increases expression ISO RGD:1320444 6480464 Ethanol results in increased expression of LHFPL2 mRNA CTD PMID:30319688 ethanol affects expression ISO RGD:1320444 6480464 Ethanol affects the expression of LHFPL2 mRNA CTD PMID:30319688 fipronil increases expression EXP 6480464 fipronil results in increased expression of LHFPL2 mRNA CTD PMID:23962444 fulvestrant multiple interactions ISO RGD:1320443 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of LHFPL2 gene CTD PMID:31601247 genistein increases expression ISO RGD:1320444 6480464 Genistein results in increased expression of LHFPL2 mRNA CTD PMID:32186404 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of LHFPL2 mRNA CTD PMID:33387578 indometacin multiple interactions ISO RGD:1320443 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of LHFPL2 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of LHFPL2 mRNA CTD PMID:28628672 lipopolysaccharide decreases expression ISO RGD:1320444 6480464 Lipopolysaccharides results in decreased expression of LHFPL2 mRNA CTD PMID:26582142 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of LHFPL2 mRNA CTD PMID:28801915 methimazole increases expression EXP 6480464 Methimazole results in increased expression of LHFPL2 mRNA CTD PMID:22504374 methylarsonic acid multiple interactions ISO RGD:1320444 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of LHFPL2 mRNA CTD PMID:34876320 N-Nitrosopyrrolidine increases expression ISO RGD:1320443 6480464 N-Nitrosopyrrolidine results in increased expression of LHFPL2 mRNA CTD PMID:32234424 ozone multiple interactions ISO RGD:1320444 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of LHFPL2 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in increased expression of LHFPL2 mRNA CTD PMID:34911549 paracetamol increases expression ISO RGD:1320443 6480464 Acetaminophen results in increased expression of LHFPL2 mRNA CTD PMID:29067470 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of LHFPL2 mRNA CTD PMID:33387578 perfluorononanoic acid increases expression ISO RGD:1320443 6480464 perfluoro-n-nonanoic acid results in increased expression of LHFPL2 mRNA CTD PMID:32588087 phenobarbital affects expression ISO RGD:1320443 6480464 Phenobarbital affects the expression of LHFPL2 mRNA CTD PMID:19159669 phenobarbital affects expression ISO RGD:1320444 6480464 Phenobarbital affects the expression of LHFPL2 mRNA CTD PMID:23091169 piroxicam increases expression ISO RGD:1320443 6480464 Piroxicam results in increased expression of LHFPL2 mRNA CTD PMID:21858171 silicon dioxide increases expression ISO RGD:1320444 6480464 Silicon Dioxide results in increased expression of LHFPL2 mRNA CTD PMID:29203145 , PMID:29341224 sodium arsenate decreases expression ISO RGD:1320444 6480464 sodium arsenate results in decreased expression of LHFPL2 mRNA CTD PMID:21795629 sodium arsenate multiple interactions ISO RGD:1320444 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of LHFPL2 mRNA CTD PMID:34876320 sodium arsenite multiple interactions ISO RGD:1320444 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of LHFPL2 mRNA CTD PMID:34876320 testosterone multiple interactions ISO RGD:1320443 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of LHFPL2 mRNA CTD PMID:21592394 testosterone increases expression ISO RGD:1320443 6480464 Testosterone results in increased expression of LHFPL2 mRNA CTD PMID:21592394 tetrachloromethane affects expression ISO RGD:1320444 6480464 Carbon Tetrachloride affects the expression of LHFPL2 mRNA CTD PMID:17484886 thapsigargin decreases expression ISO RGD:1320443 6480464 Thapsigargin results in decreased expression of LHFPL2 mRNA CTD PMID:22378314 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of LHFPL2 mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:1320444 6480464 titanium dioxide results in increased expression of LHFPL2 mRNA CTD PMID:23409001 tremolite asbestos increases expression ISO RGD:1320444 6480464 tremolite results in increased expression of LHFPL2 mRNA CTD PMID:29279043 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of LHFPL2 mRNA CTD PMID:33387578 triclosan decreases expression ISO RGD:1320443 6480464 Triclosan results in decreased expression of LHFPL2 mRNA CTD PMID:30510588 triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of LHFPL2 mRNA CTD PMID:30589522 triptonide decreases expression ISO RGD:1320444 6480464 triptonide results in decreased expression of LHFPL2 mRNA CTD PMID:33045310 troglitazone increases expression ISO RGD:1320444 6480464 troglitazone results in increased expression of LHFPL2 mRNA CTD PMID:28973697 tunicamycin decreases expression ISO RGD:1320443 6480464 Tunicamycin results in decreased expression of LHFPL2 mRNA CTD PMID:22378314 valproic acid affects expression ISO RGD:1320443 6480464 Valproic Acid affects the expression of LHFPL2 mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:1320444 6480464 Valproic Acid results in increased expression of LHFPL2 mRNA CTD PMID:24896083 vancomycin decreases expression ISO RGD:1320444 6480464 Vancomycin results in decreased expression of LHFPL2 mRNA CTD PMID:18930951
